Immix Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Immix Biopharma, Inc. has filed 239 SEC EDGAR filings since 20 Jul 2021

SEC filing history

Showing 101-125 of 239 matching filings.

Per page
25
Current page
5
D File 021-513789

D filing

Filing date
20 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 May 2024
Reporting date
15 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 May 2024
Reporting date
20 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 May 2024
Reporting date
15 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 May 2024
Reporting date
15 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 May 2024
Reporting date
15 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 May 2024
Reporting date
15 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 May 2024
Reporting date
20 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 May 2024
Reporting date
14 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 May 2024
Reporting date
14 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-41159

10-Q filing

Filing date
09 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
ARS File 001-41159

ARS filing

Filing date
30 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41159

DEF 14A filing

Filing date
29 Apr 2024
Reporting date
29 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-41159

10-K filing

Filing date
29 Mar 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
S-8 File 333-277163

S-8 filing

Filing date
20 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-269100

424B5 filing

Filing date
07 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93202

SC 13G filing

Filing date
07 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-269100

424B5 filing

Filing date
05 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Dec 2023
Reporting date
08 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-41159

10-Q filing

Filing date
13 Nov 2023
Reporting date
30 Sep 2023
Next action
Verify source filing
4/A

4/A filing

Filing date
09 Nov 2023
Reporting date
14 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
09 Nov 2023
Reporting date
14 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .